HS-20094
Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or Obesity
Regeneron · Phase 2 · Not yet recruiting · Enrollment 300
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.